Error: Could not add to watchlist. X
+ Watchlist

Valeant Pharmaceuticals International

4107485Q:US
Acquired
4107485Q:US was acquired by VRX:CN
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
3.35
Market Cap (USD)
-
Shares Outstanding (m)
75.922
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Valeant Pharmaceuticals International operates as a research-based, specialty pharmaceutical company. The Company discovers, develops, manufactures, and markets a range of pharmaceutical products as well as focusing on products in the areas of infectious disease, neurology, and dermatology. Valeant Pharmaceuticals markets its products worldwide.
Address
7545 Irvine Center Drive
Suite 100
Irvine, CA 92618
United States
Phone
1-949-461-6000